icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2021
Back grey_arrow_rt.gif
 
 
 
Risk of Multiple Drug Interactions Potentially Linked to Safety in Patients
Receiving Pangenotypic Direct-acting Antivirals for the Treatment of Hepatitis C

 
 
  AASLD 2021 Nov 12-16
 
Juan Turnes1, Antonio García-Herola2, Ramón Morillo3, Marinela Méndez4, Magdalena Rueda4, Cándido Hernández5, Antoni Sicras-Mainar6 1Gastroenterology and Hepatology Department, CHU. Pontevedra, Spain; 2Digestive Medicine Department. Hospital Marina Baixa de Villajoyosa (Alicante), Spain; 3Hospital Pharmacy, Hospital de Valme, AGS Sur de Sevilla, Spain; 4Medical Affairs, Gilead Sciences S.L., Madrid, Spain; 5Global Medical Affairs, Gilead Sciences Europe Ltd, U.K; 6Health Economics and Outcomes Research, Atrys Health, Barcelona, Spain

1113211

1113212

1113213

1113214

1113215

1113216

1113217

1113218

1113219

11132110